Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

CRAMERS DENTALLABORATORIUM ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.2%   Bankruptcy risk   11.6% 6.9% 10.0% 13.7% 11.1% 10.8% 20.2% 17.2%   Credit score (0-100)   23 37 26 17 22 21 5 9   Credit rating   BB BBB BB BB BB BB B BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   346 546 403 350 362 386 0.0 0.0   EBITDA   57.8 180 0.7 -36.0 -11.5 -74.6 0.0 0.0   EBIT   55.1 178 -0.4 -36.0 -11.5 -74.6 0.0 0.0   Pre-tax profit (PTP)   50.1 175.1 -3.1 -38.1 -14.1 -76.4 0.0 0.0   Net earnings   38.2 136.2 -5.0 -32.0 -11.1 -59.9 0.0 0.0   Pre-tax profit without non-rec. items   50.1 175 -3.1 -38.1 -14.1 -76.4 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Tangible assets total   3.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   63.1 199 194 162 151 91.3 -33.7 -33.7   Interest-bearing liabilities   0.0 0.0 0.0 2.4 3.5 3.5 33.7 33.7   Balance sheet total (assets)   149 304 233 183 196 183 0.0 0.0   Net Debt   -26.9 -194 -132 -97.9 -57.6 -68.0 33.7 33.7     See the entire balance sheet 1000.0 Volume  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   346 546 403 350 362 386 0.0 0.0   Gross profit growth   0.0% 57.8% -26.2% -13.3% 3.5% 6.5% -100.0% 0.0%   Employees   0 0 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   149 304 233 183 196 183 0 0   Balance sheet change%   0.0% 104.2% -23.4% -21.4% 7.4% -6.7% -100.0% 0.0%   Added value   57.8 180.4 0.7 -36.0 -11.5 -74.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   1 -6 -2 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 -1.0 -2.0 -3.0 -4.0 0.0 0.0   1000.0 Profitability  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   15.9% 32.5% -0.1% -10.3% -3.2% -19.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   37.0% 78.5% -0.1% -17.3% -6.1% -39.3% 0.0% 0.0%   ROI %   87.3% 135.4% -0.2% -20.1% -7.2% -59.8% 0.0% 0.0%   ROE %   60.5% 103.8% -2.5% -17.9% -7.1% -49.4% 0.0% 0.0%   1000.0 Solidity  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Equity ratio %   42.4% 65.6% 83.6% 88.8% 77.0% 49.8% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -46.6% -107.3% -17,774.4% 271.5% 501.3% 91.2% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 1.5% 2.3% 3.9% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 173.8% 86.8% 52.2% 0.0% 0.0%   1000.0 Liquidity  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Quick Ratio   1.5 2.7 5.6 7.9 3.9 1.8 0.0 0.0   Current Ratio   1.7 2.9 6.1 8.9 4.3 2.0 0.0 0.0   Cash and cash equivalent   26.9 193.5 132.4 100.3 61.2 71.6 0.0 0.0   1000.0 Capital use efficiency  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   59.2 198.2 194.3 162.3 151.2 91.3 -16.8 -16.8   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 1 -36 -11 -75 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 1 -36 -11 -75 0 0   EBIT / employee   0 0 -0 -36 -11 -75 0 0   Net earnings / employee   0 0 -5 -32 -11 -60 0 0